DDW Video Store
Drug Discovery World
A Multi-Omic Study to Characterize the Effects of a Glucosylceramide Inhibitor on Obesity

In this video poster from ASMS 2014, Robert Tonge of Waters presents a study that qualitatively and quantitatively characterizes the effects of a glucosylceramide inhibitor on obesity.

Obesity is a growing problem for human health which has reached epidemic proportions affecting over 500 million people worldwide. The condition arises due to abnormal or excessive fat accumulation that can lead to further health implications such as type 2 diabetes, heart and liver disease and potential links to various forms of cancer.